News release

Suspension of cord blood collections in response to COVID-19 pandemic

Monday, March 16, 2020

March 16, 2020 – Following new recommendations from the Public Health Agency of Canada, as well as increasing hospital restrictions and resource availability, Canadian Blood Services’ Cord Blood Bank will temporarily suspend its collections at 11 p.m. this evening (March 16, 2020) for an indefinite period to contribute to the collective efforts in limiting the spread of COVID-19.

We realize this decision may affect many families who had registered to donate their babies’ cord blood at one of our four cord blood collection hospitals across the country.  

For patients who might be concerned, Canadian Blood Services Stem Cell Program continues to follow all standards and regulations as per usual, and we are working within the latest recommendations from the World Marrow Donor Association (WMDA) — an international network of registries and cord blood banks that share a global database where all potential donors and cord blood units are listed. We will continue to help patients get the stem cells they need.

Canadian Blood Services will also continue to work closely with provincial/territorial partners, the Public Health Agency of Canada, Health Canada, Héma-Quebec, international blood agencies, and the World Health Organization to monitor the COVID-19 situation. We will resume collections as soon as deemed appropriate.

For the latest information, visit our COVID-19 update.


Suspension of group swabbing events in response to COVID-19 pandemic

Friday, March 13, 2020

March 13, 2020 – Effective immediately, Canadian Blood Services is suspending all buccal swabbing events across the country and encouraging the public to register online to get their swab kit delivered in the mail.

This suspension aligns with guidance from the Public Health Agency of Canada to minimize the amount of time individuals spend in large crowds or in crowded spaces in order to reduce the transmission of COVID-19. It also is consistent with the public health measures being implemented by many of the provinces 

The safety of registrants and their families is of utmost importance to us. We will be re-assessing this decision in 30 days.

For patients and families who might be concerned, both Canadian Blood Services Stem Cell Registry and Canadian Blood Services’ Cord Blood Bank are members of the World Marrow Donor Association (WMDA) — an international network of registries and cord blood banks that share a global database where all potential donors and cord blood units are listed. As cases of COVID-19 continue to emerge across the world, WMDA has launched a special COVID-19 webpage that is publicly available and updated regularly when new information is shared by member organizations, professional societies and courier companies. 

Canadian Blood Services will continue to monitor the COVID-19 situation and provide updates as they are received. Our stem cell registry will continue to coordinate searches in Canada, as well as other international registries to help patients get the stem cells they need. Any critical information is being communicated to the corresponding transplant centre and/or registry to ensure that life-saving products are safely transported to patients in need. Our donors will continue to be screened for active infections and travel history. 

In addition to the cancellation of the swabbing events, Canadian Blood Services is also suspending our popular “What’s Your Type” events across the country. These are events that are frequently held in public spaces like shopping malls inviting people to find out their blood types. We will revisit this cancellation as well in the coming weeks. 

If you require assistance regarding activations currently in progress for any of the international registries in countries where COVID-19 cases have been recorded, please reach out to the transplant services coordinator team at

For the latest information, visit our COVID-19 update


Organ and Tissue Donation and Transplantation – System Progress Report 2018

Monday, March 02, 2020

March 2, 2020 – Canadian Blood Services is pleased to deliver its latest System Progress Report for Organ and Tissue Donation and Transplantation (OTDT). The 2018 report was completed in collaboration with Canada’s organ donation organizations, and with the financial support of Health Canada and the provincial and territorial governments.  

In 2018, the generous gifts of 1,317 organ donors and 4,824 tissue donors and their families saved or improved the lives of thousands of Canadian patients. 

This latest data shows Canada’s performance in terms of deceased organ donation and transplantation remains stable, experiencing only a minor decline when compared to the previous year’s results. Inversely, living donation rates nationally have improved slightly.  

In 2018, a total of 223 Canadians died while waiting for a suitable transplant opportunity. For every patient in Canada who receives a lifesaving organ transplant, there are two on a waitlist. As such, there remains much work yet to be done.  

The results reflected in this report represent the individual and collective work of the provincial and territorial partners, organ donation programs, and transplant programs as well as the national efforts led by Canadian Blood Services. 

Quick stats from the 2018 System Progress 

  • The generous gifts of 1,317 organ donors and 4,824 tissue donors and their families saved or improved the lives of thousands of Canadian patients. 
  • 2,829 Canadians received a life changing transplant.  
  • 2018 saw the first decline in deceased donation in eight years, resulting in a 6% drop in the national transplant rate compared to 2017. 
  • In 2018, there were 762 deceased organ donors in Canada. In addition, there were 555 living organ donors. 
  • The Kidney Paired Donation program has facilitated an average of three transplants every two weeks from 2010 to 2018, transplants that wouldn’t have been possible without interprovincial organ sharing. 
  • Canada still has a shortage of organs, with approximately 4,351 patients waiting for transplants at year’s end 2018. 
  • In 2018, 223 Canadians died while waiting for a transplant, down from 242 in 2017. 

“Given Canadian Blood Services’ experience as the national coordinating body for OTDT in Canada and our knowledge of the components required for success, we believe that national priorities in this realm must continue to focus on strategies that will advance interprovincial organ sharing, improve living donation rates, assist jurisdictions as they implement leading practices, and enhance system performance measurements and accountability mechanisms. Patients with the greatest need, and those whose clinical profiles are most difficult to match, benefit when organs are shared across provincial boundaries.” 

  • Dr. Graham D. Sher, CEO, Canadian Blood Services 

“We seem to have hit a new plateau in living donation rates, which means as a country we have to drill down on how to get system performance to the next level. To be on par with countries like the United States, where rates are far ahead of ours, we need to make improving practice in jurisdictions with low rates a key focus. Given the wide variation in practice across Canada today, believe we have a huge opportunity to improve living kidney donation rates.” 

  • Dr. Peter Nickerson, Medical Advisor, System Performance, Data and Transplantation, Canadian Blood Services 

“Organ donation is a gift of life. The donation and transplant system in Canada is deeply grateful to the increasing number of Canadians who have donated organs to save other Canadians. While there has been a slight decrease in donors and transplants over a single year from 2017 to 2018, the system has performed extremely well over the past decade. Over the past 10 years, there has been 57% increase in the number of Canadians who have donated organs after their tragic death. This has led to a 35% increase in the number of life-saving or life-preserving transplants performed and a decrease in the number of patients on the waiting list.” 

  • Dr. Sam Shemie, Medical Advisor, Deceased Donation, Canadian Blood Services 


Organ and Tissue Donation and Transplantation – System Progress Report 2018 (PDF)


Plasma-derived drug now used for two diseases may have potential to treat others

Wednesday, August 21, 2019

August 21, 2019 (TORONTO)A treatment now used to fight two diseases might have the potential to help patients with other conditions, too, according to new research funded by Canadian Blood Services.

The new publication, “Treating murine inflammatory diseases with an anti-erythrocyte antibody,” came out today in Science Translational Medicine, a high-impact scientific journal.

Canadian Blood Services supplies hospitals with anti-D, a medication made from human plasma, to treat the autoimmune disease immune thrombocytopenia (ITP) and to prevent hemolytic disease of the fetus and newborn. Plasma is the protein-rich liquid in blood that helps other blood components circulate throughout the body. Anti-D is a solution of antibodies against a protein on red blood cells, made from the plasma of donors. At this time, anti-D isn’t recommended as a treatment for any other diseases.

In this new study, Dr. Alan Lazarus, a research scientist and immunologist at the Canadian Blood Services Centre for Innovation, discovered that a red blood cell antibody called Ter119 works in three mouse models of inflammatory arthritis, as well as one model of transfusion-related acute lung injury (TRALI). TRALI is very rare, but it’s one of the leading causes of transfusion-related deaths, and there is no good treatment for it. These findings suggest that anti-D may be a possible treatment for these diseases in humans.

“The knowledge that anti-D could be used to treat TRALI as well as autoimmune diseases other than ITP is good news for patients,” says Dr. Lazarus. “This may have broad therapeutic potential.”

If it’s demonstrated to work in humans, this approach may also provide an alternative to immune suppression, which is how doctors typically approach autoimmune disorders, but not a good option for everyone.

This work is basic research using mouse models, and an essential step in improving medical understanding and opening doors to new possibilities for better patient care.

Dr. Alan Lazarus is a scientist at St. Michael’s Hospital’s Keenan Research Centre for Biomedical Science and a professor at the University of Toronto. This work received funding support from Canadian Blood Services, funded by the federal government (Health Canada) and the provincial and territorial ministries of health. The views expressed in the publication do not necessarily reflect the views of the federal government of Canada, or provincial or territorial governments. The work also received funding from Canadian Institutes of Health Research, CSL Limited, and CSL Behring, a biopharmaceutical company that produces human anti-D.

About research at Canadian Blood Services:

Through discovery, development and applied research, Canadian Blood Services drives world-class innovation in blood transfusion, cellular therapy and transplantation — bringing clarity and insight to an increasingly complex healthcare future.

Our dedicated research team and extended network of partners engage in exploratory and applied research to create new knowledge, inform and enhance best practices, contribute to the development of new services and technology, and build capacity through training and collaboration. Find out more about our research impact.

TEL. 1-877-709-7773


Extraordinary story of Dr. Shelly Sarwal to premiere at 2019 FIN Atlantic International Film Festival

Wednesday, August 14, 2019

August 14, 2019 (HALIFAX) Her Last Project, a film that chronicles a remarkable woman’s end-of-life journey, premieres on Sept. 13 as part of the FIN Atlantic International Film Festival’s documentary program. This extraordinary documentary follows Dr. Shelly Sarwal’s story of taking control of her destiny and leaving a lasting legacy.

Diagnosed with multiple system atrophy, an incurable disease, Dr. Shelly Sarwal chose to end her life through medical assistance in dying (MAID) and to become an organ and tissue donor. As the first person in Nova Scotia to undergo the complicated medical journey of donation after MAID, it was Shelly’s wish to share her experience as a way to educate the public and the medical community.

After saying goodbye to her closest friends over toast and tea, Shelly died peacefully, with her husband at her side. Her organ donation was a gift that impacted many lives.

Her Last Project is directed by Emmy-nominated Rosvita Dransfeld and produced by Canadian Blood Services, in partnership with Legacy of Life at the Nova Scotia Health Authority. 

This powerful film debuts in Shelly’s hometown of Halifax, where she worked and taught, where she lived her life among friends and family, and where she documented her final days for the benefit of others.

The premiere screening of Her Last Project takes place at 6:20 p.m. on Friday, Sept. 13 in Theatre 3 of the Cineplex Cinemas Park Lane in Halifax.

Visit to learn more.


“Our team first met and worked with Shelly as a patient partner. She helped us to develop national guidelines for health professionals involved in organ donation who, due to the passing of MAID legislation, were faced with the reality of having to care for and engage a new group of potential donors. This was unfamiliar territory for organ donation specialists and the public. Shelly and her family bravely and selflessly invited us to chronicle her journey over many months through the MAID process and subsequent organ and tissue donation. Her gift saved lives and serves to educate the broader health system on this important issue. We are honored to have had this opportunity to tell her story.”   

  • Amber Appleby, Executive Producer. Appleby is also the director of Organ and Tissue Donation and Transplantation at Canadian Blood Services.  

“It was the first time in my career that I’d collaborated with health agencies in this way. The team at Canadian Blood Services and NSHA remained highly respectful of Shelly’s and my vision for the film. Although already weakened and frail, Shelly remained committed to educate the public about MAID and organ donation. I am honoured to have worked on this project and to have met this woman extraordinaire.”   

  • Rosvita Dransfeld, Director. Dransfeld is an internationally renowned documentary filmmaker who crafts powerful explorations of the human condition connecting the audience to the subjects on screen in a way that is both moving and respectful. Dransfeld has produced two other high-profile documentaries related to organ donation and transplant, Memento Mori and Vital BondsTransplanting Hope, an adaptation of Vital Bonds, has just been nominated for an Emmy.  

“Dr. Shelly Sarwal was an extraordinary woman who I had the privilege to know first as a patient and then as a colleague and friend. At a time when many of us would look for privacy, Shelly opened up her life to strangers so that they might learn more about end of life compassion, medical assistance in dying and the gift of organ donation. She was passionate about educating health professionals and the public on all of these issues. I’m grateful for the opportunity to have worked with her and learned so much from her during this project.”

  • Dr. Jennifer Hancock, Intensivist, QEII Health Sciences Centre, Halifax, N.S.
Learn more
About Canadian Blood Services

Canadian Blood Services operates with a national scope and infrastructure that makes it unique within the Canadian health care system. In the domain of organs and tissues Canadian Blood Services manages programs that facilitate interprovincial organ sharing and works in collaboration with provincial programs and partners to improve the organ donation and transplantation system. Initiatives led by Canadian Blood Services include the development of leading practices, professional education, public and professional awareness campaigns, and system performance data collection, analysis and reporting.

  • Every year, thousands of Canadians are added to organ waitlists. There are more than 4,400 people waiting for organ transplants in Canada and an estimated 250 die while waiting for a transplant.

  • A single organ donor can save up to eight lives. Eye and tissue donors can improve the lives of up to 75 patients.

Learn more about organ and tissue donation in Canada at

For more information, email or call 1-877-709-7773.

About Legacy of Life and Nova Scotia Health Authority

Nova Scotia Health Authority (NSHA) provides health services to Nova Scotians and a wide array of specialized services to Maritimers and Atlantic Canadians. NSHA operates hospitals, health centres and community-based programs across the province. Our team of health professionals includes employees, doctors, researchers, learners and volunteers. Visit for more.

Legacy of Life is the provincial deceased donation program for Nova Scotia. Established in 2006, the program strives to ensure every Nova Scotian knows about deceased donation and is routinely provided with the opportunity to become a donor as part of optimal end-of-life care. This is achieved through education of the public and healthcare community, adherence to leading care practices and donor family support.

Media contacts

Canadian Blood Services: 1-877-709-7773 /

Nova Scotia Health Authority: 1-844-483-3344 /


Securing Canada’s plasma supply

Tuesday, August 06, 2019

With dedicated collection sites in Ontario, Alberta and British Columbia

August 06, 2019 (OTTAWA) – Canadian Blood Services is pleased to announce that with the support of funding governments, plans are now underway to increase plasma collection with three proof-of-concept sites in Sudbury, ON, Lethbridge, AB, and Kelowna, B.C.

These sites will be dedicated to the collection of source plasma, which is the blood component used to make specialized medicines from the proteins in human plasma. The protein products that are derived from source plasma are used in the treatment of patients with a variety of life-threatening conditions. In addition to the three sites in Sudbury, Lethbridge and Kelowna, Canadian Blood Services will continue to collect plasma through the blood collection process at other donor centres across the country.

Usage of one plasma protein product, Immune globulin (Ig), has doubled internationally over the past ten years. Ig is used to treat primary immunodeficiency disorders, a group of rare chronic disorders in which part of the immune system is missing or functioning improperly. Secondary immunodeficiencies, which result from non-genetic factors such as viruses and chemotherapy, are also treated with Ig.

Canadian Blood Services has identified the decrease in plasma sufficiency – the percentage of Ig product delivered to Canadian patients that is produced from plasma collected in Canada by Canadian Blood Services, the national agency mandated by provinces and territories to do so – as a material risk needing mitigation.

“Canadian Blood Services is responsible for ensuring a safe and secure supply of plasma, and for mitigating the risks and impacts of the growing global demand for plasma protein products such as Ig, within Canada’s national healthcare system,” says Dr. Graham Sher, CEO, Canadian Blood Services.

“Opening these stand-alone sites will allow us to increase plasma collection and halt the current downward trend in Canada’s source plasma sufficiency levels. By increasing the domestic plasma supply we can continue to be responsive to the needs of Canadian patients, today and into the future,” adds Dr. Sher.

The Sudbury site will be the first to open, with collection from eligible donors expected to get underway by the Spring 2020, followed by Lethbridge in Fall 2020, and Kelowna in Spring 2021. These locations were chosen based on criteria for optimal conditions to allow collection of voluntary, unpaid donations.

The purpose of the proof-of-concept approach will be to further test and perfect a new collections model that is separate and distinct from the one currently used to collect whole blood. The model adheres to the founding principles of voluntary, unpaid donation in Canada, and builds on Canadian Blood Services’ extensive expertise and decades of experience in whole blood collection, combined with industry best practices and the cumulative knowledge acquired from other blood operators that are meeting their sufficiency targets. The goal is to secure domestic plasma sufficiency in Canada for Canadian patients in the most sustainable, cost-effective and scalable manner possible. 


Share your reasons campaign boosts National Blood Donor Week, June 10-16

Monday, June 10, 2019

Donors celebrated for supporting Canada’s Lifeline

JUNE 10, 2019 (OTTAWA) – To support National Blood Donor Week, June 10 to 16, Canadian Blood Services is launching a new online tool ( for anyone whose life has been changed by blood products to share their reason(s) for joining Canada’s Lifeline and help patients.

“Each year during National Blood Donor Week and on World Blood Donor Day, June 14, we celebrate and thank donors for their generosity and commitment to patients. Blood donors are a vital link in Canada’s Lifeline and more donors are needed to maintain a strong and consistent supply of blood and blood products. We encourage Canadians to visit our website and to share their personal reasons for donating and inspire their friends and family to join them,” says Rick Prinzen, Canadian Blood Services chief supply chain officer and vice-president of donor relations.

“After seeing my mom and sister not being well, as soon as I turned 17 I knew I would donate,” says Jakob Gallant whose mother Lori and sister Keelyn both suffer from platelet coagulation disorder and require blood transfusions regularly. “It wasn’t even something I had to think about. It’s funny because neither of them really looks sick. And they aren’t right now thankfully, but it will happen again. And they will need help again as will a lot more people that I know. You never know when someone close to you may need it,” says Jakob.

“My wife receiving a blood transfusion was a huge motivator to boost my donations,” says Byron Link, a retired RCMP officer who donated his first pint of blood in Manitoba in 1965 at age 21. In 1996 while stationed in Prince George, B.C., his wife became ill and a blood transfusion saved her life. In 2002, Byron and his wife moved to Kamloops, B.C. where he continued to donate as often as he could. Last year on May 22, 2018, he made his milestone 150th donation and since then has donated four more times.

“Everything we do to help patients in Canada depends on donors who give so selflessly and are very dedicated,” says Prinzen. “Many Canadians have reasons for donating blood and the donations ultimately help patients through difficult health challenges and allow them to wake up healthier, every day.”

Visitors to the new web page can submit their reason(s) for donating blood or plasma, registering as a stem cell or organ and tissue donor, volunteering or giving financially. And, as a continuation of the “Reasons” multi-media campaign the organization launched in April, Canadians are also invited to use social media to post their reason(s) for being a donor, tag their followers and encourage them to do the same using the hash tags #WhatsYourReason, #NBDW2019 and #WBDD.

While we take this week to thank existing donors, Canadian patients also need new donors to join Canada’s Lifeline. This year, over 100,000 new blood donors are needed to maintain the national blood supply and meet the needs of patients who require blood transfusions. Canadians are encouraged to donate blood this summer to meet anticipated hospital demand. Blood donations often decrease during summer months because of holidays, changes in routines, travel and family activities.

Legislated by the Government of Canada in 2008, National Blood Donor Week recognizes and celebrates donors who selflessly help their fellow citizens. Events will be held in communities across the country throughout National Blood Donor Week to thank generous donors for their commitment to patients and to encourage new donors to join Canada’s Lifeline.

Making an appointment to donate has never been easier. Download the GiveBlood app, call 1 888 2 DONATE (1-888-236-6283) or book now at Walk-in appointments are also available at all locations.

About Canadian Blood Services
Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma and stem cells, we provide services for patients on behalf of all provincial and territorial governments except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories, as a biological lifeline for Canadians.

TEL. 1-877-709-7773


Canadian Blood Services board meeting open to the public

Tuesday, June 18, 2019

(TORONTO) On June 20, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at, and inviting the public to attend in person in Toronto.

Twice each year, members of the public are invited to participate in open board meetings. They have the opportunity to hear about the organization’s work, deliver presentations to the board, and meet with members of the board and the management team. 

Since its creation in 1998, Canadian Blood Services has been committed to operating in an open, transparent, and collaborative manner. 


Dr. Graham Sher, CEO, Canadian Blood Services, and members of the Executive Management Team 

Mel Cappe, Chair of the Board of Directors, and members of the Board of Directors 


Thursday, June 20, 2019 
8:30 a.m. to 12:30 p.m. EDT 


Metro Toronto Convention Centre 
255 Front Street West 
Toronto, ON 

Live-stream available at 

About Canadian Blood Services 

Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma and stem cells, we provide services for patients on behalf of all provincial and territorial governments except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories, as a biological lifeline for Canadians. 


Organ and tissue donation by those who choose medical assistance in dying: navigating this emerging area

Monday, June 03, 2019

June 3, 2019 (OTTAWA) –  A new publication in CMAJ (Canadian Medical Association Journal) aims to help health care teams navigate clinical issues surrounding organ and tissue donation by patients who choose to donate after medical assistance in dying (MAID) or withdrawal of life-sustaining measures. 

In collaboration with the Canadian Critical Care Society, the Canadian Society of Transplantation, and the Canadian Association of Critical Care Nurses, Canadian Blood Services brought together medical, legal and ethics experts to inform this work, as well as patient partners who brought unique perspectives and thoughtful insight. 

“Canadian Blood Services is proud to have supported the development of this important guidance to help clinicians navigate organ donation for patients who have chosen MAID,” says Amber Appleby, director of organ and tissue donation and transplantation with Canadian Blood Services. 

Deceased organ and tissue donation is a common practice that saves or improves lives worldwide. For the thousands of Canadians who receive a transplant every year, 3 out of 4 transplanted organs come from deceased donors. 

The new publication, Organ and Tissue Donation for Medical Assistance in Dying and Other Conscious Competent Patients: Expert Guidance for Policy, makes key recommendations, including:  

  • Protection for patients – the decision to have MAID or withdrawal of life-sustaining measures must occur before any discussion of organ donation. 

  • Choice – medically suitable conscious competent patients who provide first-person consent to end-of-life procedures should be given the opportunity to donate organs and tissues. 

  • Consent – the patient must be able to provide first-person consent and be able to withdraw consent for MAID or donation at any time. 

  • Donor testing – physicians, transplant teams and other staff should try to minimize the impact and disruption of donating (such as testing) for the patient. 

  • Determination of death – the dead donor must be respected, meaning vital organs can only be removed from deceased donors after determination of death according to accepted criteria. 

  • Conscientious objection – health-care professionals may choose not to participate in MAID or withdrawal of life-sustaining measures, but they should work to support the patient’s wishes to donate. 

To help health care teams, the publication includes an easy-to-reference table with the complete recommendations. 

Read the publication here, or listen to CMAJ’s podcast.  

TEL. 1-877-709-7773 


More reasons than ever to join Canada’s Lifeline

Wednesday, May 15, 2019

Donors play vital role in meeting the needs of patients every day

MAY 15, 2019 (OTTAWA) – Canadian Blood Services is launching a new national multi-media campaign it hopes will give Canadians many new and compelling reasons to support patients and help save lives.

The ‘Reasons’ campaign urges potential donors to join Canada’s Lifeline and demonstrates situations that highlight why blood and blood products are needed every day to treat a broad range of patient needs, from trauma to cancer treatments. This campaign builds on Canadian Blood Services renewed brand and expanded commitment to Canadian patients introduced last September on its 20-year-anniversary.

“We believe if more people better understand the multitude of reasons we need regular donors to come forward, Canadians will make that commitment,” says Rick Prinzen, Canadian Blood Services chief supply chain officer and vice-president of donor relations.

“Many people have come to know and love our original tag line “It’s in you to give.” But after 20 years, Canadian Blood Services is about more than just blood. Our new tag line, “Together, we are Canada’s Lifeline” encourages people to think about the power of connections to keep Canadians living. It’s about doing something today knowing that, because of us, someone else is waking up healthier tomorrow. There are many ways to join Canada’s lifeline and help patients, including donating blood or plasma, registering as a stem cell or organ and tissue donor, and by volunteering or giving financially.”

Radio spots have been running in markets across Canada since mid-April. The next phase of the campaign starts May 20 when :30 and :15 second television ads launch in greater Vancouver, Toronto, Ottawa and Halifax.

“We are really excited about the new campaign and are confident it will help highlight why we need donors every day,” says Prinzen. “There is always a reason to donate. Patients are counting on blood donors to book now to donate before and after the Victoria Day long weekend, when donations tend to decrease as people are away or busy with other activities,” he says.

Spring, summer, fall, winter—no matter the season, the need for blood, stem cells, plasma and organ and tissue donors is constant. Canadians will soon be hearing a lot of additional reasons to join Canada’s Lifeline. What’s your reason?

Making an appointment to donate has never been easier. Download the GiveBlood app, call 1 888 2 DONATE (1-888-236-6283) or book now at Walk-in appointments are also available at all locations.

About Canadian Blood Services
Canadian Blood Services is a not-for-profit charitable organization. Regulated by Health Canada as a biologics manufacturer and primarily funded by the provincial and territorial ministries of health, Canadian Blood Services operates with a national scope, infrastructure and governance that make it unique within Canadian healthcare. In the domain of blood, plasma and stem cells, we provide services for patients on behalf of all provincial and territorial governments except Quebec. The national transplant registry for interprovincial organ sharing and related programs reaches into all provinces and territories, as a biological lifeline for Canadians.

TEL. 1-877-709-7773